Global RNA Modified Pseudouridine Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243125

Publication Date:

November 7, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.
The global RNA Modified Pseudouridine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩NA Modified Pseudouridine Industry Forecast鈥� looks at past sales and reviews total world RNA Modified Pseudouridine sales in 2022, providing a comprehensive analysis by region and market sector of projected RNA Modified Pseudouridine sales for 2023 through 2029. With RNA Modified Pseudouridine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Modified Pseudouridine industry.
This Insight Report provides a comprehensive analysis of the global RNA Modified Pseudouridine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNA Modified Pseudouridine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global RNA Modified Pseudouridine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Modified Pseudouridine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Modified Pseudouridine.
United States market for RNA Modified Pseudouridine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for RNA Modified Pseudouridine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for RNA Modified Pseudouridine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key RNA Modified Pseudouridine players cover YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Modified Pseudouridine market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solution
Powder
Segmentation by Application:
mRNA Vaccines
Gene Expression and Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Solution
Powder
Segmentation by Application:
mRNA Vaccines
Gene Expression and Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Modified Pseudouridine Market Size 2019-2030
2.1.2 RNA Modified Pseudouridine Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for RNA Modified Pseudouridine by Country/Region, 2019, 2023 & 2030
2.2 RNA Modified Pseudouridine Segment by Type
2.2.1 Solution
2.2.2 Powder
2.3 RNA Modified Pseudouridine Market Size by Type
2.3.1 RNA Modified Pseudouridine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global RNA Modified Pseudouridine Market Size Market Share by Type (2019-2024)
2.4 RNA Modified Pseudouridine Segment by Application
2.4.1 mRNA Vaccines
2.4.2 Gene Expression and Therapy
2.4.3 Other
2.5 RNA Modified Pseudouridine Market Size by Application
2.5.1 RNA Modified Pseudouridine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global RNA Modified Pseudouridine Market Size Market Share by Application (2019-2024)
3 RNA Modified Pseudouridine Market Size by Player
3.1 RNA Modified Pseudouridine Market Size Market Share by Player
3.1.1 Global RNA Modified Pseudouridine Revenue by Player (2019-2024)
3.1.2 Global RNA Modified Pseudouridine Revenue Market Share by Player (2019-2024)
3.2 Global RNA Modified Pseudouridine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RNA Modified Pseudouridine by Region
4.1 RNA Modified Pseudouridine Market Size by Region (2019-2024)
4.2 Global RNA Modified Pseudouridine Annual Revenue by Country/Region (2019-2024)
4.3 Americas RNA Modified Pseudouridine Market Size Growth (2019-2024)
4.4 APAC RNA Modified Pseudouridine Market Size Growth (2019-2024)
4.5 Europe RNA Modified Pseudouridine Market Size Growth (2019-2024)
4.6 Middle East & Africa RNA Modified Pseudouridine Market Size Growth (2019-2024)
5 Americas
5.1 Americas RNA Modified Pseudouridine Market Size by Country (2019-2024)
5.2 Americas RNA Modified Pseudouridine Market Size by Type (2019-2024)
5.3 Americas RNA Modified Pseudouridine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Modified Pseudouridine Market Size by Region (2019-2024)
6.2 APAC RNA Modified Pseudouridine Market Size by Type (2019-2024)
6.3 APAC RNA Modified Pseudouridine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe RNA Modified Pseudouridine Market Size by Country (2019-2024)
7.2 Europe RNA Modified Pseudouridine Market Size by Type (2019-2024)
7.3 Europe RNA Modified Pseudouridine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Modified Pseudouridine by Region (2019-2024)
8.2 Middle East & Africa RNA Modified Pseudouridine Market Size by Type (2019-2024)
8.3 Middle East & Africa RNA Modified Pseudouridine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global RNA Modified Pseudouridine Market Forecast
10.1 Global RNA Modified Pseudouridine Forecast by Region (2025-2030)
10.1.1 Global RNA Modified Pseudouridine Forecast by Region (2025-2030)
10.1.2 Americas RNA Modified Pseudouridine Forecast
10.1.3 APAC RNA Modified Pseudouridine Forecast
10.1.4 Europe RNA Modified Pseudouridine Forecast
10.1.5 Middle East & Africa RNA Modified Pseudouridine Forecast
10.2 Americas RNA Modified Pseudouridine Forecast by Country (2025-2030)
10.2.1 United States Market RNA Modified Pseudouridine Forecast
10.2.2 Canada Market RNA Modified Pseudouridine Forecast
10.2.3 Mexico Market RNA Modified Pseudouridine Forecast
10.2.4 Brazil Market RNA Modified Pseudouridine Forecast
10.3 APAC RNA Modified Pseudouridine Forecast by Region (2025-2030)
10.3.1 China RNA Modified Pseudouridine Market Forecast
10.3.2 Japan Market RNA Modified Pseudouridine Forecast
10.3.3 Korea Market RNA Modified Pseudouridine Forecast
10.3.4 Southeast Asia Market RNA Modified Pseudouridine Forecast
10.3.5 India Market RNA Modified Pseudouridine Forecast
10.3.6 Australia Market RNA Modified Pseudouridine Forecast
10.4 Europe RNA Modified Pseudouridine Forecast by Country (2025-2030)
10.4.1 Germany Market RNA Modified Pseudouridine Forecast
10.4.2 France Market RNA Modified Pseudouridine Forecast
10.4.3 UK Market RNA Modified Pseudouridine Forecast
10.4.4 Italy Market RNA Modified Pseudouridine Forecast
10.4.5 Russia Market RNA Modified Pseudouridine Forecast
10.5 Middle East & Africa RNA Modified Pseudouridine Forecast by Region (2025-2030)
10.5.1 Egypt Market RNA Modified Pseudouridine Forecast
10.5.2 South Africa Market RNA Modified Pseudouridine Forecast
10.5.3 Israel Market RNA Modified Pseudouridine Forecast
10.5.4 Turkey Market RNA Modified Pseudouridine Forecast
10.6 Global RNA Modified Pseudouridine Forecast by Type (2025-2030)
10.7 Global RNA Modified Pseudouridine Forecast by Application (2025-2030)
10.7.1 GCC Countries Market RNA Modified Pseudouridine Forecast
11 Key Players Analysis
11.1 YAMASA CORPORATION
11.1.1 YAMASA CORPORATION Company Information
11.1.2 YAMASA CORPORATION RNA Modified Pseudouridine Product Offered
11.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 YAMASA CORPORATION Main Business Overview
11.1.5 YAMASA CORPORATION Latest Developments
11.2 Biosynth Carbosynth
11.2.1 Biosynth Carbosynth Company Information
11.2.2 Biosynth Carbosynth RNA Modified Pseudouridine Product Offered
11.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biosynth Carbosynth Main Business Overview
11.2.5 Biosynth Carbosynth Latest Developments
11.3 TriLink BioTechnologies
11.3.1 TriLink BioTechnologies Company Information
11.3.2 TriLink BioTechnologies RNA Modified Pseudouridine Product Offered
11.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 TriLink BioTechnologies Main Business Overview
11.3.5 TriLink BioTechnologies Latest Developments
11.4 MP Biomedicals, Inc
11.4.1 MP Biomedicals, Inc Company Information
11.4.2 MP Biomedicals, Inc RNA Modified Pseudouridine Product Offered
11.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 MP Biomedicals, Inc Main Business Overview
11.4.5 MP Biomedicals, Inc Latest Developments
11.5 Thermo Scientific Chemicals
11.5.1 Thermo Scientific Chemicals Company Information
11.5.2 Thermo Scientific Chemicals RNA Modified Pseudouridine Product Offered
11.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Thermo Scientific Chemicals Main Business Overview
11.5.5 Thermo Scientific Chemicals Latest Developments
11.6 BOC Sciences
11.6.1 BOC Sciences Company Information
11.6.2 BOC Sciences RNA Modified Pseudouridine Product Offered
11.6.3 BOC Sciences RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BOC Sciences Main Business Overview
11.6.5 BOC Sciences Latest Developments
11.7 Toronto Research Chemical
11.7.1 Toronto Research Chemical Company Information
11.7.2 Toronto Research Chemical RNA Modified Pseudouridine Product Offered
11.7.3 Toronto Research Chemical RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Toronto Research Chemical Main Business Overview
11.7.5 Toronto Research Chemical Latest Developments
11.8 Wuhan Glycogene
11.8.1 Wuhan Glycogene Company Information
11.8.2 Wuhan Glycogene RNA Modified Pseudouridine Product Offered
11.8.3 Wuhan Glycogene RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Wuhan Glycogene Main Business Overview
11.8.5 Wuhan Glycogene Latest Developments
11.9 Fine Biotech
11.9.1 Fine Biotech Company Information
11.9.2 Fine Biotech RNA Modified Pseudouridine Product Offered
11.9.3 Fine Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Fine Biotech Main Business Overview
11.9.5 Fine Biotech Latest Developments
11.10 Shanghai Hongene Biotech
11.10.1 Shanghai Hongene Biotech Company Information
11.10.2 Shanghai Hongene Biotech RNA Modified Pseudouridine Product Offered
11.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Shanghai Hongene Biotech Main Business Overview
11.10.5 Shanghai Hongene Biotech Latest Developments
11.11 Biori
11.11.1 Biori Company Information
11.11.2 Biori RNA Modified Pseudouridine Product Offered
11.11.3 Biori RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Biori Main Business Overview
11.11.5 Biori Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂